Norway Peptide Therapeutics Market Size & Outlook, 2026-2033
The peptide therapeutics market in Norway is expected to reach a projected revenue of US$ 2,290.5 million by 2033. A compound annual growth rate of 8.3% is expected of Norway peptide therapeutics market from 2026 to 2033.
Revenue, 2025 (US$M)
$1,108.0
Estimate, 2026 (US$M)
$1,315.0
Forecast, 2033 (US$M)
$2,290.5
CAGR, 2026 - 2033
8.3%
Global Market
Related Markets
Norway peptide therapeutics market highlights
- The Norway peptide therapeutics market generated a revenue of USD 1,108.0 million in 2025 and is expected to reach USD 2,290.5 million by 2033.
- The Norway market is expected to grow at a CAGR of 8.3% from 2026 to 2033.
- In terms of segment, metabolic disorders was the largest revenue generating application in 2025.
- Metabolic disorders is the most lucrative application segment registering the fastest growth during the forecast period.
Peptide therapeutics market data book summary
| Market revenue in 2025 | USD 1,108.0 million |
| Market revenue in 2033 | USD 2,290.5 million |
| Growth rate | 8.3% (CAGR from 2026 to 2033) |
| Largest segment | Metabolic disorders |
| Fastest growing segment | Metabolic disorders |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Gastrointestinal disorders, Cancer, Metabolic disorders, Cardiovascular disorders, Pain, Respiratory disorders, Infectious disease, Dermatological disorders, Renal disorders, Neurological disorders |
| Key market players worldwide | Eli Lilly and Co, Pfizer Inc, Amgen Inc, Takeda Pharmaceutical Co Ltd, AstraZeneca PLC, Teva Pharmaceutical Industries Ltd, Sanofi SA, Roche Holding AG, Novartis AG ADR, Novo Nordisk A/S ADR, GlaxoSmithKline, Ironwood Pharmaceuticals Inc Class A, Ipsen SA, Radius Health |
Other key industry trends
- In terms of revenue, Norway accounted for 0.8% of the global peptide therapeutics market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Europe, Germany peptide therapeutics market is projected to lead the regional market in terms of revenue in 2033.
- Denmark is the fastest growing regional market in Europe and is projected to reach USD 2,481.8 million by 2033.
No credit card required*
Publish Date: Apr 20, 2026
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Three ways to get this data
Subscribe to the databook, customize it, or ask a question.Horizon Databook
Unlock every chart on this page and get dashboard access
- Statistics1.2M+ across all markets
- Databooks30K+ global, 120K+ country
- Companies200K+ profiles
- ExportPDF, Dashboard, XLS & PNG, licensed to cite
Customize it
Customize data as per your requirement
- AddCountries, segments, years
- RecutTo your product definition
- ExtendCompany-level detail
- OrA bespoke databook
- Turnaround5–10 working days
Ask Prism AI
A cited answer in seconds
- Corpus30,000 studies, 1.2M points
- ScopeAll markets, not just this
- CitationTraced to report & table
- HonestySays "not covered" if so
- SpeedSeconds, not days
Peptide Therapeutics Market Scope
Peptide Therapeutics Market segmentation & scope
Others
Others
Peptide Therapeutics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Novartis AG ADR | View profile | 76,057 | Lichtstrasse 35, Basel, Switzerland, 4056 | www.novartis.com |
| Teva Pharmaceutical Industries Ltd | View profile | 37,851 | 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 | www.tevapharm.com |
| Amgen Inc | View profile | 26,700 | One Amgen Center Drive, Thousand Oaks, CA, United States, 91320-1799 | www.amgen.com |
| Pfizer Inc | View profile | 88,000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | www.pfizer.com |
| Sanofi SA | View profile | 87,994 | 46, avenue de la Grande Armée, Paris, France, 75017 | www.sanofi.com |
| Roche Holding AG | View profile | 103,605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | www.roche.com |
| Eli Lilly and Co | View profile | 43,000 | Lilly Corporate Center, Indianapolis, IN, United States, 46285 | www.lilly.com |
| Novo Nordisk A/S ADR | View profile | 66,015 | Novo Alle 1, Bagsvaerd, Denmark, 2880 | www.novonordisk.com |
| AstraZeneca PLC | View profile | 89,900 | 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA | www.astrazeneca.com |
| Takeda Pharmaceutical Co Ltd | View profile | 49,095 | 1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, Japan, 103-8668 | www.takeda.com |
Norway Peptide Therapeutics Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Peptide Therapeutics Market Outlook will help companies and investors design strategic landscapes.
Metabolic Disorders was the largest segment with a revenue share of 77.51% in 2025.
Horizon Databook has segmented the Norway peptide therapeutics market based on gastrointestinal disorders, cancer, metabolic disorders, cardiovascular disorders, pain, respiratory disorders, infectious disease, dermatological disorders, renal disorders, neurological disorders covering the revenue growth of each sub-segment from 2021 to 2033.
- Norway Peptide Therapeutics Market Application Outlook (Revenue, USD Million , 2021-2033)
- Cancer
- Metabolic disorders
- Cardiovascular disorders
- Respiratory disorders
- Gastrointestinal disorders
- Infectious disease
- Pain
- Dermatological disorders
- Neurological disorders
- Renal disorders
- Others
- Norway Peptide Therapeutics Market Type Outlook (Revenue, USD Million , 2021-2033)
- Generic
- Innovative
- Norway Peptide Therapeutics Market Type of Manufacturers Outlook (Revenue, USD Million , 2021-2033)
- Inhouse
- Outsourced
- Norway Peptide Therapeutics Market Route of Administration Outlook (Revenue, USD Million , 2021-2033)
- Parenteral Route
- Oral Route
- Pulmonary
- Mucosal
- Others
- Norway Peptide Therapeutics Market Synthesis Technology Outlook (Revenue, USD Million , 2021-2033)
- Recombinant DNA Technology
- Solid-Phase Peptide Synthesis (SPPS)
- Hybrid
- Liquid-Phase Peptide Synthesis (LPPS)
- Others
- Norway Peptide Therapeutics Market Type of Manufacturer Outlook (Revenue, USD Million , 2021-2033)
- Inhouse
- Outsourced
Reasons to subscribe to Peptide Therapeutics Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Peptide Therapeutics Market Outlook databook
- Our clientele includes a mix of Peptide Therapeutics Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Norway Peptide Therapeutics Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Norway Peptide Therapeutics Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Norway Peptide Therapeutics Market, 2021-2033 (US$M)
Norway peptide therapeutics market statistics, by application, 2021-2033 (US$M)
